Work

Abstract LB358: BPI-585771: A novel, potent pan-KRAS degrader with potent in vitro and in vivo efficacy in KRAS-driven tumors

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-lb358

Authors: Zhengqing Li, Renqi Xu, Yanju Liu, Jiayu Zhao, Ying Zhao, Tianyi Ma, Tao Zhang, Bo Yan, Liang Chen, Jing Guo, Cheng Yang, Han Han, Xiaoyun Liu, Haibo Chen, Quan Zhou, Hong Lan, Li Mao, Lieming Ding

Institution: Betta Pharmaceuticals (China)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154708285

Cites:

Cited by:

Related to: